Additional information

Mycoplasma testing is the process of identifying contamination which can have major effects on cell line growth and characteristics. Global mycoplasma testing market value is projected to be $523.3 Million in 2017 and is expected to generate revenue of around $1193 Million by the end of 2024, growing at a CAGR of around 12.50% between 2019 and 2024. Rising cell culture contamination and the strong trend of R&D investments in life sciences are the factors enhancing the growth of the market. Shortage of skilled professionals and a high degree of consolidation acts as an entry barrier for new entrants are the factors which hamper the market growth. Private exchanges providing great market potential and increasing pharmaceutical outsourcing are the opportunities for mycoplasma testing market.

Analysis and conclusions on the future mycoplasma testing market outlook.

Top-down and bottom-up approaches are used to validate the mycoplasma testing market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The mycoplasma testing market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the mycoplasma testing market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The mycoplasma testing market segmentation is as follows:

By Technique

PCR

Elisa

Direct assays

Indirect assays

DNA staining

Microbial culture techniques

Enzymatic methods

By Application

Cell line testing

Virus testing

End-of-production cell testing

Other applications

By Product & Service

Kits & reagents

Instruments

Services

By End User

Pharmaceutical and biotechnology companies

Contract research organizations

Academic research institutes

Cell banks

Other end users

Geographical Analysis:

Mycoplasma testing market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. The Asia Pacific is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the mycoplasma testing market include:

Scope Revision

Geographic Analysis

Company Profiles

Historical Data & Forecasting

Key Contact Persons in companies

Global Mycoplasma Testing Market Research Report Includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact on altering market dynamics.

Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

Identify the latest developments, market shares and strategies that are employed by the significant mycoplasma testing market players, such as

Thermo Fisher Scientific, Inc.

The Merck Group

Promo Cell GmbH.

American Type Culture Collection.

Charles River Laboratories International, Inc.

Along with these companies, many other companies are considered in the report while analysing the global mycoplasma testing competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.

CHAPTER 1 INTRODUCTION

1.1. Market Definition

1.2. Executive Summary

1.3. The Scope of the Study

CHAPTER 2 RESEARCH METHODOLOGY

2.1. Secondary Research

2.2. Primary Research

2.3. Analytic Tools and Model

2.4. Economic Indicator

2.4.1. Base Year, Base Currency, Forecasting Period

2.5. Expert Validation

2.6. Study Timeline

CHAPTER 3 MARKET ANALYSIS

3.1. Industry Value Chain Analysis

3.2. Porter’s Five Force Analysis

3.2.1. Bargaining Power of Buyers

3.2.2. Bargaining Power of Suppliers

3.2.3. Threats of Substitutes

3.2.4. Threats of New Entrants

3.2.5. Degree of Competition

3.3. PESTLE Analysis

3.3.1. Political

3.3.2. Economical

3.3.3. Social

3.3.4. Technological

3.3.5. Legal

3.3.6. Environmental

3.4. SWOT Analysis

3.4.1. Strengths

3.4.2. Weakness

3.4.3. Opportunities

3.4.4. Threats

3.5. Y-O-Y Analysis

CHAPTER 4 MARKET DYNAMICS

4.1. Market Drivers

4.1.1. Rising cell culture contamination

4.1.2. Increasing growth and government support for pharmaceutical and biotechnology industries

4.1.3. The strong trend of R&D investments in life sciences

4.1.4. Strict regulatory requirements

4.2. Market Restraints & Challenges

4.2.1. Shortage of skilled professionals

4.2.2. High degree of consolidation acts as an entry barrier for new entrants

4.3. Market Opportunities

4.3.1. Private exchanges providing great market potential

4.3.2. Increasing pharmaceutical outsourcing

CHAPTER 5 GLOBAL MYCOPLASMA TESTING MARKET – BY TECHNIQUE

5.1. Introduction

5.2. Enzymatic methods

5.3. Microbial culture techniques

5.4. DNA Staining

5.5. PCR

5.6. Elisa

5.7. Direct assays

5.8. Direct assays

CHAPTER 6 GLOBAL MYCOPLASMA TESTING MARKET – BY PRODUCT & SERVICE

6.1. Introduction

6.2. Instruments

6.3. Kits & reagents

6.3.1. PCR Assays

6.3.2. Nucleic acid detection kits

6.3.3. Elimination kits & reagents

6.3.4. Stains

6.3.5. Standards & controls

6.3.6. Other kits & reagents

6.4. Services

CHAPTER 7 GLOBAL MYCOPLASMA TESTING MARKET – BY APPLICATION

7.1. Introduction services

7.2. End-of-production cell testing

7.3. Cell line testing

7.4. Virus testing

7.5. Other applications

CHAPTER 8 GLOBAL MYCOPLASMA TESTING MARKET – BY END USER

8.1. Introduction

8.2. Academic research institutes

8.3. Cell banks

8.4. Pharmaceutical and biotechnology companies

8.5. Contract research organizations

8.6. Other end users

CHAPTER 9 GLOBAL MYCOPLASMA TESTING MARKET – BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.2.3. Mexico

9.2.4. Costa Rica

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Chile

9.3.4. Columbia

9.3.5. Others

9.4. Europe

9.4.1. U.K.

9.4.2. Germany

9.4.3. France

9.4.4. Italy

9.4.5. Spain

9.4.6. Russia

9.4.7. Netherlands

9.4.8. Switzerland

9.4.9. Poland

9.4.10. Others

9.5. Asia Pacific

9.5.1. China

9.5.2. Japan

9.5.3. India

9.5.4. South Korea

9.5.5. Australia & New Zealand

9.5.6. Malaysia

9.5.7. Singapore

9.5.8. Others

9.6. Middle East & Africa

9.6.1. UAE

9.6.2. Saudi Arabia

9.6.3. Iran

9.6.4. Iraq

9.6.5. Qatar

9.6.6. South Africa

9.6.7. Algeria

9.6.8. Morocco

9.6.9. Nigeria

9.6.10. Egypt

9.6.11. Others

CHAPTER 10 GLOBAL MYCOPLASMA TESTING MARKET – COMPANY PROFILES

10.1. Thermo Fisher Scientific, Inc.

10.2. The Merck Group,

10.3. Lonza Group Ltd.

10.4. Promo Cell GmbH

10.5. American Type Culture Collection

10.6. Charles River Laboratories International, Inc.

10.7. Bionique Testing Laboratories, Inc.

10.8. Biological Industries Ltd.

10.9. InvivoGen,

10.10. WuXi AppTec Group

10.11. Norgen Biotek Corp.

10.12. SGS S.A.

10.13. F. Hoffmann-La Roche Ltd.

10.14. UnitedHealth Group Inc.

10.15. Allianz SE.

CHAPTER 11 GLOBAL MYCOPLASMA TESTING MARKET – COMPETITIVE LANDSCAPE

11.1. Market Share Analysis

11.2. Strategies adopted by top companies

11.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 12 MARKET INSIGHTS

12.1. Industry Experts Insights

12.2. Analysts Opinions

12.3. Investment Opportunities

CHAPTER 13 APPENDIX

13.1. List of Tables

13.2. List of Figures

Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.

Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.

The Regional and Global Variety is taken care of in the report.

Year on Year basis generation of revenue is studied.

Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.

The overview and the sustainability of the market are analyzed through SWOT.

DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.

The segment-level analysis in terms of type and technology.

The value chain analysis, value that's created and captured by a company is the profit margin.

Value Created and Captured – Cost of Creating that Value = Margin

An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.

Basis on the depth of the study we approach using analytical tools

Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

Mycoplasma testing is the process of identifying contamination which can have major effects on cell line growth and characteristics. Global mycoplasma testing market value is projected to be $523.3 Million in 2017 and is expected to generate revenue of around $1193 Million by the end of 2024, growing at a CAGR of around 12.50% between 2019 and 2024. Rising cell culture contamination and the strong trend of R&D investments in life sciences are the factors enhancing the growth of the market. Shortage of skilled professionals and a high degree of consolidation acts as an entry barrier for new entrants are the factors which hamper the market growth. Private exchanges providing great market potential and increasing pharmaceutical outsourcing are the opportunities for mycoplasma testing market.

Analysis and conclusions on the future mycoplasma testing market outlook.

Top-down and bottom-up approaches are used to validate the mycoplasma testing market size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The mycoplasma testing market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the mycoplasma testing market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.

The scope of the Report

The mycoplasma testing market segmentation is as follows:

By Technique

PCR

Elisa

Direct assays

Indirect assays

DNA staining

Microbial culture techniques

Enzymatic methods

By Application

Cell line testing

Virus testing

End-of-production cell testing

Other applications

By Product & Service

Kits & reagents

Instruments

Services

By End User

Pharmaceutical and biotechnology companies

Contract research organizations

Academic research institutes

Cell banks

Other end users

Geographical Analysis:

Mycoplasma testing market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. The Asia Pacific is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.

Customization Options:

With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the mycoplasma testing market include:

Scope Revision

Geographic Analysis

Company Profiles

Historical Data & Forecasting

Key Contact Persons in companies

Global Mycoplasma Testing Market Research Report Includes:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact on altering market dynamics.

Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

Identify the latest developments, market shares and strategies that are employed by the significant mycoplasma testing market players, such as

Thermo Fisher Scientific, Inc.

The Merck Group

Promo Cell GmbH.

American Type Culture Collection.

Charles River Laboratories International, Inc.

Along with these companies, many other companies are considered in the report while analysing the global mycoplasma testing competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.

CHAPTER 1 INTRODUCTION

1.1. Market Definition

1.2. Executive Summary

1.3. The Scope of the Study

CHAPTER 2 RESEARCH METHODOLOGY

2.1. Secondary Research

2.2. Primary Research

2.3. Analytic Tools and Model

2.4. Economic Indicator

2.4.1. Base Year, Base Currency, Forecasting Period

2.5. Expert Validation

2.6. Study Timeline

CHAPTER 3 MARKET ANALYSIS

3.1. Industry Value Chain Analysis

3.2. Porter’s Five Force Analysis

3.2.1. Bargaining Power of Buyers

3.2.2. Bargaining Power of Suppliers

3.2.3. Threats of Substitutes

3.2.4. Threats of New Entrants

3.2.5. Degree of Competition

3.3. PESTLE Analysis

3.3.1. Political

3.3.2. Economical

3.3.3. Social

3.3.4. Technological

3.3.5. Legal

3.3.6. Environmental

3.4. SWOT Analysis

3.4.1. Strengths

3.4.2. Weakness

3.4.3. Opportunities

3.4.4. Threats

3.5. Y-O-Y Analysis

CHAPTER 4 MARKET DYNAMICS

4.1. Market Drivers

4.1.1. Rising cell culture contamination

4.1.2. Increasing growth and government support for pharmaceutical and biotechnology industries

4.1.3. The strong trend of R&D investments in life sciences

4.1.4. Strict regulatory requirements

4.2. Market Restraints & Challenges

4.2.1. Shortage of skilled professionals

4.2.2. High degree of consolidation acts as an entry barrier for new entrants

4.3. Market Opportunities

4.3.1. Private exchanges providing great market potential

4.3.2. Increasing pharmaceutical outsourcing

CHAPTER 5 GLOBAL MYCOPLASMA TESTING MARKET – BY TECHNIQUE

5.1. Introduction

5.2. Enzymatic methods

5.3. Microbial culture techniques

5.4. DNA Staining

5.5. PCR

5.6. Elisa

5.7. Direct assays

5.8. Direct assays

CHAPTER 6 GLOBAL MYCOPLASMA TESTING MARKET – BY PRODUCT & SERVICE

6.1. Introduction

6.2. Instruments

6.3. Kits & reagents

6.3.1. PCR Assays

6.3.2. Nucleic acid detection kits

6.3.3. Elimination kits & reagents

6.3.4. Stains

6.3.5. Standards & controls

6.3.6. Other kits & reagents

6.4. Services

CHAPTER 7 GLOBAL MYCOPLASMA TESTING MARKET – BY APPLICATION

7.1. Introduction services

7.2. End-of-production cell testing

7.3. Cell line testing

7.4. Virus testing

7.5. Other applications

CHAPTER 8 GLOBAL MYCOPLASMA TESTING MARKET – BY END USER

8.1. Introduction

8.2. Academic research institutes

8.3. Cell banks

8.4. Pharmaceutical and biotechnology companies

8.5. Contract research organizations

8.6. Other end users

CHAPTER 9 GLOBAL MYCOPLASMA TESTING MARKET – BY GEOGRAPHY

9.1. Introduction

9.2. North America

9.2.1. U.S.

9.2.2. Canada

9.2.3. Mexico

9.2.4. Costa Rica

9.3. South America

9.3.1. Brazil

9.3.2. Argentina

9.3.3. Chile

9.3.4. Columbia

9.3.5. Others

9.4. Europe

9.4.1. U.K.

9.4.2. Germany

9.4.3. France

9.4.4. Italy

9.4.5. Spain

9.4.6. Russia

9.4.7. Netherlands

9.4.8. Switzerland

9.4.9. Poland

9.4.10. Others

9.5. Asia Pacific

9.5.1. China

9.5.2. Japan

9.5.3. India

9.5.4. South Korea

9.5.5. Australia & New Zealand

9.5.6. Malaysia

9.5.7. Singapore

9.5.8. Others

9.6. Middle East & Africa

9.6.1. UAE

9.6.2. Saudi Arabia

9.6.3. Iran

9.6.4. Iraq

9.6.5. Qatar

9.6.6. South Africa

9.6.7. Algeria

9.6.8. Morocco

9.6.9. Nigeria

9.6.10. Egypt

9.6.11. Others

CHAPTER 10 GLOBAL MYCOPLASMA TESTING MARKET – COMPANY PROFILES

10.1. Thermo Fisher Scientific, Inc.

10.2. The Merck Group,

10.3. Lonza Group Ltd.

10.4. Promo Cell GmbH

10.5. American Type Culture Collection

10.6. Charles River Laboratories International, Inc.

10.7. Bionique Testing Laboratories, Inc.

10.8. Biological Industries Ltd.

10.9. InvivoGen,

10.10. WuXi AppTec Group

10.11. Norgen Biotek Corp.

10.12. SGS S.A.

10.13. F. Hoffmann-La Roche Ltd.

10.14. UnitedHealth Group Inc.

10.15. Allianz SE.

CHAPTER 11 GLOBAL MYCOPLASMA TESTING MARKET – COMPETITIVE LANDSCAPE

11.1. Market Share Analysis

11.2. Strategies adopted by top companies

11.3. Mergers, Acquisitions, Collaborations & Agreements

CHAPTER 12 MARKET INSIGHTS

12.1. Industry Experts Insights

12.2. Analysts Opinions

12.3. Investment Opportunities

CHAPTER 13 APPENDIX

13.1. List of Tables

13.2. List of Figures

Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.

Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.

The Regional and Global Variety is taken care of in the report.

Year on Year basis generation of revenue is studied.

Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.

The overview and the sustainability of the market are analyzed through SWOT.

DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.

The segment-level analysis in terms of type and technology.

The value chain analysis, value that's created and captured by a company is the profit margin.

Value Created and Captured – Cost of Creating that Value = Margin

An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.

Basis on the depth of the study we approach using analytical tools

Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.

Envision Inteligence is the Main Supplier of Market Analysis Reviews, Customized Consulting Companies, Information Analytics and Trade Evaluation. Our purpose is to offer the correct data required by the stakeholder on the proper level of time.Read More